Related Articles
Genetic alteration of p53, but not overexpression of intratumoral p53 protein, or serum p53 antibody is a prognostic factor in sporadic colorectal adenocarcinoma
C-erbB-2 expression is a better predictor for survival than galectin-3 or p53 in early-stage breast cancer
p53R2 expression as a prognostic biomarker in early stage non-small cell lung cancer
Altered expression of cyclin E and the retinoblastoma protein influences the effect of adjuvant therapy in breast cancer
Validation of biomarkers associated with 5-fluorouracil and thymidylate synthase in colorectal cancer